Effects of the porcupine inhibitor, LGK974, on RNF43 mutant and wild type colorectal cancer cell lines

被引：0
|
作者：
Bond, C. [1 ]
Kalimutho, M. [2 ]
Bettington, M. [1 ,3 ,4 ]
Pearson, S. [1 ]
Leggett, B. [1 ,4 ,5 ]
Whitehall, V. [1 ,4 ,6 ]
机构：
[1] QIMR Berghofer Med Res Inst, Conjoint Gastroenterol Lab, Brisbane, Qld, Australia
[2] QIMR Berghofer Med Res Inst, Signal Transduct Lab, Brisbane, Qld, Australia
[3] Envoi Specialist Pathologists, Brisbane, Qld, Australia
[4] Univ Queensland, Brisbane, Qld, Australia
[5] Royal Brisbane & Womens Hosp, Brisbane, Qld, Australia
[6] Pathol Queensland, Brisbane, Qld, Australia
来源：
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY | 2015年 / 30卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：73 / 73
页数：1
相关论文
共 50 条
  • [41] Synergistic Effects of Metformin Treatment in Combination with Gefitinib, a Selective EGFR Tyrosine Kinase Inhibitor, in LKB1 Wild-type NSCLC Cell Lines
    Morgillo, Floriana
    Sasso, Ferdinando Carlo
    Della Corte, Carminia Maria
    Vitagliano, Donata
    D'Aiuto, Elena
    Troiani, Teresa
    Martinelli, Erika
    De Vita, Ferdinando
    Orditura, Michele
    De Palma, Raffaele
    Ciardiello, Fortunato
    CLINICAL CANCER RESEARCH, 2013, 19 (13) : 3508 - 3519
  • [42] Expression of Retroviral Mediated Wild Type p53 Gene in Laryngocarcinoma and Fibrosarcoma Cell Lines and Its Inhibitory Effects on Cancer Growth
    陈晓巍
    HighTechnologyLetters, 1996, (01) : 103 - 106
  • [43] AKT is critically involved in the antagonism of BRAF inhibitor sorafenib against dabrafenib in colorectal cancer cells harboring both wild-type and mutant (V600E) BRAF genes
    Wang, Hongbin
    Quan, Haitian
    Lou, Liguang
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2017, 489 (01) : 14 - 20
  • [44] The HSP90 inhibitor ganetespib potentiates the antitumor activity of EGFR tyrosine kinase inhibition in mutant and wild-type non-small cell lung cancer
    Donald L. Smith
    Jaime Acquaviva
    Manuel Sequeira
    John-Paul Jimenez
    Chaohua Zhang
    Jim Sang
    Richard C. Bates
    David A. Proia
    Targeted Oncology, 2015, 10 : 235 - 245
  • [45] The HSP90 inhibitor ganetespib potentiates the antitumor activity of EGFR tyrosine kinase inhibition in mutant and wild-type non-small cell lung cancer
    Smith, Donald L.
    Acquaviva, Jaime
    Sequeira, Manuel
    Jimenez, John-Paul
    Zhang, Chaohua
    Sang, Jim
    Bates, Richard C.
    Proia, David A.
    TARGETED ONCOLOGY, 2015, 10 (02) : 235 - 245
  • [46] Thymidylate synthase inhibition triggers apoptosis via caspases-8 and-9 in both wild-type and mutant p53 colon cancer cell lines
    Backus, HHJ
    Wouters, D
    Ferreira, CG
    van Houten, VMM
    Brakenhoff, RH
    Pinedo, HM
    Peters, GJ
    EUROPEAN JOURNAL OF CANCER, 2003, 39 (09) : 1310 - 1317
  • [47] Effects of gamma irradiation on cell cycle, apoptosis and telomerase activity in p53 wild-type and deficient HCT116 colon cancer cell lines
    Halacli, Sevil Oskay
    Canpinar, Hande
    Cimen, Eren
    Sunguroglu, Asuman
    ONCOLOGY LETTERS, 2013, 6 (03) : 807 - 810
  • [48] Natural Merosesquiterpenes Activate the DNA Damage Response via DNA Strand Break Formation and Trigger Apoptotic Cell Death in p53-Wild-Type and Mutant Colorectal Cancer
    Jiso, Apisada
    Demuth, Philipp
    Bachowsky, Madeleine
    Haas, Manuel
    Seiwert, Nina
    Heylmann, Daniel
    Rasenberger, Birgit
    Christmann, Markus
    Dietrich, Lea
    Brunner, Thomas
    Riyanti
    Schaeberle, Till F.
    Plubrukarn, Anuchit
    Fahrer, Joerg
    CANCERS, 2021, 13 (13)
  • [49] Metabolism of the EGFR tyrosin kinase inhibitor gefitinib by cytochrome P450 1A1 enzyme in EGFR-wild type non small cell lung cancer cell lines
    Alfieri, Roberta R.
    Galetti, Maricla
    Tramonti, Stefano
    Andreoli, Roberta
    Mozzoni, Paola
    Cavazzoni, Andrea
    Bonelli, Mara
    Fumarola, Claudia
    La Monica, Silvia
    Galvani, Elena
    De Palma, Giuseppe
    Mutti, Antonio
    Mor, Marco
    Tiseo, Marcello
    Mari, Ettore
    Ardizzoni, Andrea
    Petronini, Pier Giorgio
    MOLECULAR CANCER, 2011, 10
  • [50] Metabolism of the EGFR tyrosin kinase inhibitor gefitinib by cytochrome P450 1A1 enzyme in EGFR-wild type non small cell lung cancer cell lines
    Roberta R Alfieri
    Maricla Galetti
    Stefano Tramonti
    Roberta Andreoli
    Paola Mozzoni
    Andrea Cavazzoni
    Mara Bonelli
    Claudia Fumarola
    Silvia La Monica
    Elena Galvani
    Giuseppe De Palma
    Antonio Mutti
    Marco Mor
    Marcello Tiseo
    Ettore Mari
    Andrea Ardizzoni
    Pier Giorgio Petronini
    Molecular Cancer, 10
12345